Pharmacokinetic Study and Toxicity of Leukovir: A New Combined Drug for the Treatment of Multiple Sclerosis

ISSN Print: 2162-2183
ISSN Online: 2162-2191
www.scirp.net/journal/abc
E-mail: [email protected]

Citations

"Pharmacokinetic Study and Toxicity of Leukovir: A New Combined Drug for the Treatment of Multiple Sclerosis"
written by Elena N. Kalinichenko, Irina V. Ponteleeva, Marina B. Golubeva,
published by Advances in Biological Chemistry, Vol.12 No.1, 2022

has been cited by the following article(s):

[1]	The Development of the Combination Drug Leukovir® Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
	Current Drug Targets, 2023

[2]	An in Silico Study Anti-Inflammatory Activity of Active Compounds Bouea macrophylla Griff Against Toll Like Receptors-4